Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 20, Number 10—October 2014

Treatment of Giardiasis after Nonresponse to Nitroimidazole

Eli Schwartz, Tamar Lachish, and Eli SchwartzComments to Author 
Author affiliations: The Chaim Sheba Medical Center and the Center for Geographic Medicine, Tel Hashomer,
Israel (E. Meltzer, E. Schwartz); Tel Aviv University, Tel Aviv, Israel (E. Meltzer, E. Schwartz); Shaare Zedek Medical Center, Jerusalem, Israel (T. Lachish)

Main Article

Table 1

Management of giardiasis nonresponsive to nitroimidazole treatment, Israel, January 2008–October 2013*

Patient age, y/sex Travel history No. failed nitroimidazole courses Immunologic assessment Alb Nitaz Quin Paromo
24/M Israel 9 Pan-hypogammaglobulinemia Failed† Failed NA NA
35/M Latin America 3 IgA deficiency Failed Failed Cured NA
61/M Israel 1 IgA deficiency Cured NA NA NA
23/M Latin America 1 IgA deficiency Cured‡ NA NA NA
25/M Thailand 3 Normal Failed Failed Cured NA
45/M India 3 Normal Failed Cured NA NA
31/F India 2 Normal Failed NA NA Cured‡
26/M India 1 Normal Failed NA NA Cured
23/M India 1 Normal Cured NA NA NA
24/M Thailand 1 Normal Cured NA NA NA
25/F India 2 Normal Cured‡ NA NA NA
23/F India, Thailand 1 ND Cured† NA NA NA

*Alb, albendazole; NA, not administered; ND, not done; nitaz, nitazoxanide; paromo, paromomycin; quin, quinacrine.
†Combination albendazole–tinidazole treatment.
‡Patient was clinically asymptomatic but did not provide a posttreatment fecal sample.

Main Article

Page created: September 22, 2014
Page updated: September 22, 2014
Page reviewed: September 22, 2014
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.